Department Of Health Policy And Management 1
1. The Role of Infectious Agents in Male vs Female Infertility: A Central Asian Trend
2. Factors Associated with Life Satisfaction of Older Adults in Almaty, Kazakhstan
3. Perspectives of Artificial Intelligence Use for In-House Ethics Checks of Journal Submissions
4. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
5. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
6. Development of the Health Disparities Prevention Quality Index for Medicare Accountable Care Organizations
7. Development of the Health Disparities Prevention Quality Index for Medicare Accountable Care Organizations
8. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
9. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
10. Advancing Research, Writing, and Publishing in Nursing: Addressing Challenges and Improving Standards
11. Nurses’ roles, interventions, and implications for management of rheumatic diseases
12. Predictors of cirrhosis in chronic hepatitis C: Findings from a 24-month follow-up study in Almaty, Kazakhstan
13. Mortality trends from respiratory disease in Kazakhstan: A 2011–2021 analysis
14. Diabetes and diabetic retinopathy in kazakhstan from 2013-2018.
15. Trend of Cardiovascular Diseases in the Northern Regions of the Republic of Kazakhstan at the Outpatient Level
16. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
17. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
18. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
19. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
20. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
21. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
22. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
23. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
24. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
25. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices
26. Methodological considerations in injury burden of disease studies across Europe: a systematic literature review
27. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
28. ChatGPT-4.0 as a Tool for Automated Review of Ethics and Transparency in Biomedical Literature
29. The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review
30. Physical activity of older patients with rheumatoid arthritis
31. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
32. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
33. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
34. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
35. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
36. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
37. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
38. Global Health Strategies in the Face of the COVID-19 Pandemic and Other Unprecedented Threats
39. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
40. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
41. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
42. Clinical and economic impacts of optical coherence tomography prior to cataract surgery in a low-to-middle-income country
43. Exploring frailty in the context of HIV and aging in Kazakhstan: findings from a pilot cross-sectional study
44. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
45. Developing HPV Vaccination Communication Strategies: Assessing Knowledge, Attitudes, and Barriers Among Healthcare Professionals in Kazakhstan
46. Avoidable Mortality in its Economic Impact in Almaty City, Kazakhstan
47. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
48. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
49. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
50. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
1 2 3